Back
Adaptive Biotechnologies Stock Predictions
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
71
ADPT
Adaptive Biotechnologies
Last Price:
$9.03
Seasonality Move:
19.88%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Adaptive Biotechnologies Stock Forecast
-
Over the next 52 weeks, Adaptive Biotechnologies has on average historically risen by 5.6% based on the past 5 years of stock performance.
-
Adaptive Biotechnologies has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Adaptive Biotechnologies Stock Undervalued?The current Adaptive Biotechnologies [ADPT] share price is $9.03. The Score for ADPT is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
ADPT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Adaptive Biotechnologies Stock Go Up Next Year?
-
Over the next 52 weeks, Adaptive Biotechnologies has on average historically risen by 5.6% based on the past 5 years of stock performance.
Adaptive Biotechnologies Stock Rating
Buy
71
Adaptive Biotechnologies (ADPT)
is a Buy
Is Adaptive Biotechnologies overpriced?
-
Adaptive Biotechnologies has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Adaptive Biotechnologies Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
adaptivebiotech.com
52-Week Data
52-Week High:
10.28
52-Week Low:
2.99
Prediction Charts
Market Cap:
1.4B
Price in USD:
9.03
Volume:
1.2M
Beta:
1.39
Technical Analysis
SMA50:
7.91
SMA100:
7.57
SMA200:
6.23
52-Wk Change:
153.65%
Stock Predictions
-
Is Adaptive Biotechnologies stock public?Yes, Adaptive Biotechnologies is a publicly traded company.
-
What is the Adaptive Biotechnologies stock quote today?The Adaptive Biotechnologies stock price is 9.03 USD today.
-
How to buy Adaptive Biotechnologies stock online?You can buy Adaptive Biotechnologies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-22 | 6.90 | 7.01 | 7.19 | 6.90 |
| Apr-23 | 7.42 | 7.38 | 7.86 | 7.33 |
| Apr-24 | 7.36 | 7.89 | 8.03 | 7.26 |
| Apr-25 | 7.80 | 7.90 | 7.96 | 7.68 |
| Apr-28 | 7.92 | 7.77 | 8.05 | 7.71 |
| Apr-29 | 7.76 | 7.61 | 7.80 | 7.46 |
| Apr-30 | 7.41 | 7.36 | 7.67 | 7.16 |
| May-1 | 7.44 | 7.36 | 7.51 | 7.20 |
| May-2 | 8.81 | 9.84 | 10.28 | 8.57 |
| May-5 | 9.80 | 10.03 | 10.18 | 9.47 |
| May-6 | 10.00 | 8.81 | 10.20 | 8.75 |
| May-7 | 9.04 | 8.81 | 9.11 | 8.38 |
| May-8 | 8.95 | 9.27 | 9.51 | 8.80 |
| May-9 | 9.40 | 9.03 | 9.50 | 9.03 |
Adaptive Biotechnologies Earnings
Adaptive Biotechnologies Earnings Report: Per Share Adaptive Biotechnologies Earnings Q1 Q2 Q3 and Q4 last year and next year.
Adaptive Biotechnologies Forecast Revenue Growth
Adaptive Biotechnologies Stock Analysis: Historical quarterly revenues per share for Adaptive Biotechnologies and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.27 per share, and an increase next year of $0.23 per share.
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.